The Institute of Cancer Therapeutics houses a multidisciplinary team of researchers in the field of drug design, synthesis, screening and pharmacology. Our purpose built institute is configured to integrate all the elements of the preclinical drug discovery process, in keeping with our mission to research and develop new treatments with a focus on cancer and other proliferative diseases.
The Institute has significant cancer charity, UK research council and commercial sponsorship to facilitate the progression of new therapies and experimental delivery systems.
The Knowledge Transfer activities of the Institute provide collaborative research support to the pharmaceutical and biotechnology industries.
To undertake internationally acclaimed research, knowledge transfer and teaching into all aspects of cancer medicine discovery and pharmacology in order to facilitate the preclinical and clinical understanding and development of new therapies.